Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDICT-1 Study of HLA-B*5701 Screening
NCT00340080Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 4 trial of abacavir in human immunodeficiency virus infection (HIV), sponsored by GSK. Started Apr 2006; status: completed.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00340080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00340080.